Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
STLK5(STRAPHD1) Takeda global kinase panel
Assay data:1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, activity ≤ 1 µMRelated BioAssays by Target
Inhibition of STLK5 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control
Assay data:6 Tested
SummaryRelated BioAssays by Target
Inhibition of STLK5 in human NCI-H929 cells by mass spectroscopic analysis
Assay data:2 Active, 6 Tested
SummaryCompounds, ActiveRelated BioAssays by Target
Binding affinity to LYK5 in human SUM159 cell lysates by multiplexed inhibitor bead profiling-based LC-MS/MS analysis
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
RNAi screen for vemurafenib enhancer genes in BRAFV600 melanoma - Primary Screen
Assay data:790 Active, 18119 Tested
Summary
Inhibition of STLK5 in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled YSVKVLPWLSPEVLQQNLQGYDAK probe by mass-spectrometric analysis relative to control
Assay data:3 Tested
SummaryPubMed CitationRelated BioAssays by Target
Inhibition of STLK5 activation loop (unknown origin) at 10 uM
Assay data:1 Tested
Inhibition of recombinant full-length N-terminal 6-His-tagged human LKB1/GST-tagged MO25alpha/GST-tagged STRADalpha expressed in SF21 cells at 3 uM relative to control
Inhibition of STLK5 conserved Lys2 (SVKASHILISVDGK) in human PBMC at 0.1 uM
Inhibition of STLK5 activation loop (YSVKVLPWLSPEVLQQNLQGYDAK) in human PBMC at 0.1 uM
Inhibition of STLK5 conserved Lys2 (SVKASHILISVDGK) in human PBMC at 1 uM
Inhibition of STLK5 activation loop (YSVKVLPWLSPEVLQQNLQGYDAK) in human PBMC at 1 uM
Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.
Assay data:5 Active, 2 Activity ≤ 1 µM, 237 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Primary screen of kinases in signalling pathway between Protease activated receptor 2 (PAR2) and the ion channels Transient receptor potential vanilloid-4 (TRPV4) in HEK293 cells
Assay data:91 Active, 714 Tested
Validation screen of kinases in signalling pathway between Protease activated receptor 2 (PAR2) and the ion channels Transient receptor potential vanilloid-4 (TRPV4) in HEK293 cells
Assay data:72 Active, 208 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SW620)
Assay data:15 Active, 794 Tested
SummaryPubMed CitationRelated BioAssays by Depositor
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (SNUC5)
Assay data:11 Active, 794 Tested
A screen to identify synergistic combinations in colorectal cancer - Primary Screen (HCT15)
Assay data:18 Active, 794 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on